114 related articles for article (PubMed ID: 11978889)
21. Role of heparin-binding epidermal growth factor-like growth factor as a hepatotrophic factor in rat liver regeneration after partial hepatectomy.
Kiso S; Kawata S; Tamura S; Higashiyama S; Ito N; Tsushima H; Taniguchi N; Matsuzawa Y
Hepatology; 1995 Nov; 22(5):1584-90. PubMed ID: 7590679
[TBL] [Abstract][Full Text] [Related]
22. Detection and cellular localization of heparin-binding epidermal growth factor-like growth factor mRNA and protein in human atherosclerotic tissue.
Reape TJ; Wilson VJ; Kanczler JM; Ward JP; Burnand KG; Thomas CR
J Mol Cell Cardiol; 1997 Jun; 29(6):1639-48. PubMed ID: 9220349
[TBL] [Abstract][Full Text] [Related]
23. Increased expression of heparin binding epidermal growth-factor-like growth factor mRNA in the kidney of streptozotocin-induced diabetic rats.
Lee YJ; Shin SJ; Lin SR; Tan MS; Tsai JH
Biochem Biophys Res Commun; 1995 Feb; 207(1):216-22. PubMed ID: 7857268
[TBL] [Abstract][Full Text] [Related]
24. Heparin-binding EGF-like growth factor expression increases selectively in bladder smooth muscle in response to lower urinary tract obstruction.
Borer JG; Park JM; Atala A; Nguyen HT; Adam RM; Retik AB; Freeman MR
Lab Invest; 1999 Nov; 79(11):1335-45. PubMed ID: 10576204
[TBL] [Abstract][Full Text] [Related]
25. Heparin-binding epidermal growth factor-like growth factor isoforms and epidermal growth factor receptor/ErbB1 expression in bladder cancer and their relation to clinical outcome.
Kramer C; Klasmeyer K; Bojar H; Schulz WA; Ackermann R; Grimm MO
Cancer; 2007 May; 109(10):2016-24. PubMed ID: 17394193
[TBL] [Abstract][Full Text] [Related]
26. Heparin-binding EGF-like growth factor (HB-EGF) and necrotizing enterocolitis.
Feng J; El-Assal ON; Besner GE
Semin Pediatr Surg; 2005 Aug; 14(3):167-74. PubMed ID: 16084404
[TBL] [Abstract][Full Text] [Related]
27. Effects of HB-EGF and epiregulin on wound healing of gingival cells in vitro.
Kim JM; Bak EJ; Chang JY; Kim ST; Park WS; Yoo YJ; Cha JH
Oral Dis; 2011 Nov; 17(8):785-93. PubMed ID: 21771212
[TBL] [Abstract][Full Text] [Related]
28. Effect of epidermal growth factor on experimental colitis in the rat.
Luck MS; Bass P
J Pharmacol Exp Ther; 1993 Feb; 264(2):984-90. PubMed ID: 8382288
[TBL] [Abstract][Full Text] [Related]
29. Timing, route, and dose of administration of heparin-binding epidermal growth factor-like growth factor in protection against intestinal ischemia-reperfusion injury.
Martin AE; Luquette MH; Besner GE
J Pediatr Surg; 2005 Nov; 40(11):1741-7. PubMed ID: 16291163
[TBL] [Abstract][Full Text] [Related]
30. Concomitant expression of heparin-binding epidermal growth factor-like growth factor mRNA and basic fibroblast growth factor mRNA in myocardial infarction in rats.
Iwabu A; Murakami T; Kusachi S; Nakamura K; Takemoto S; Komatsubara I; Sezaki S; Hayashi J; Ninomiya Y; Tsuji T
Basic Res Cardiol; 2002 May; 97(3):214-22. PubMed ID: 12061391
[TBL] [Abstract][Full Text] [Related]
31. Heparin binding epidermal growth factor in renal ischaemia/reperfusion injury.
Mulder GM; Nijboer WN; Seelen MA; Sandovici M; Bos EM; Melenhorst WB; Trzpis M; Kloosterhuis NJ; Visser L; Henning RH; Leuvenink HG; Ploeg RJ; Sunnarborg SW; van Goor H
J Pathol; 2010 Jun; 221(2):183-92. PubMed ID: 20225242
[TBL] [Abstract][Full Text] [Related]
32. Bladder epithelial cells from patients with interstitial cystitis produce an inhibitor of heparin-binding epidermal growth factor-like growth factor production.
Keay S; Kleinberg M; Zhang CO; Hise MK; Warren JW
J Urol; 2000 Dec; 164(6):2112-8. PubMed ID: 11061938
[TBL] [Abstract][Full Text] [Related]
33. Heparin-binding epidermal growth factor-like growth factor protects rat intestine after portal triad clamping.
Liao X; Chen L; Fu W; Zhou J
Growth Factors; 2013 Apr; 31(2):74-80. PubMed ID: 23534509
[TBL] [Abstract][Full Text] [Related]
34. Neutralizing anti-vascular endothelial growth factor (VEGF) antibody reduces severity of experimental ulcerative colitis in rats: direct evidence for the pathogenic role of VEGF.
Tolstanova G; Khomenko T; Deng X; Chen L; Tarnawski A; Ahluwalia A; Szabo S; Sandor Z
J Pharmacol Exp Ther; 2009 Mar; 328(3):749-57. PubMed ID: 19060224
[TBL] [Abstract][Full Text] [Related]
35. Heparin-binding EGF-like growth factor regulates elastin and FGF-2 expression in pulmonary fibroblasts.
Liu J; Rich CB; Buczek-Thomas JA; Nugent MA; Panchenko MP; Foster JA
Am J Physiol Lung Cell Mol Physiol; 2003 Nov; 285(5):L1106-15. PubMed ID: 12882762
[TBL] [Abstract][Full Text] [Related]
36. Protective effect of epidermal growth factor in an experimental model of colitis in rats.
Procaccino F; Reinshagen M; Hoffmann P; Zeeh JM; Lakshmanan J; McRoberts JA; Patel A; French S; Eysselein VE
Gastroenterology; 1994 Jul; 107(1):12-7. PubMed ID: 8020654
[TBL] [Abstract][Full Text] [Related]
37. Prolactin regulation by heparin-binding growth factors expressed in mouse pituitary cell lines.
Hnasko R; Ben-Jonathan N
Endocrine; 2003; 20(1-2):35-44. PubMed ID: 12668866
[TBL] [Abstract][Full Text] [Related]
38. Heparin-binding EGF-like growth factor (HB-EGF) decreases oxygen free radical production in vitro and in vivo.
Kuhn MA; Xia G; Mehta VB; Glenn S; Michalsky MP; Besner GE
Antioxid Redox Signal; 2002 Aug; 4(4):639-46. PubMed ID: 12230876
[TBL] [Abstract][Full Text] [Related]
39. Heparin and low-molecular-weight heparin (enoxaparin) significantly ameliorate experimental colitis in rats.
Dotan I; Hershkoviz R; Karmeli F; Brazowski E; Peled Y; Rachmilewitz D; Halpern Z
Aliment Pharmacol Ther; 2001 Oct; 15(10):1687-97. PubMed ID: 11564011
[TBL] [Abstract][Full Text] [Related]
40. Heparin-binding EGF-like growth factor preserves crypt cell proliferation and decreases bacterial translocation after intestinal ischemia/reperfusion injury.
Xia G; Martin AE; Michalsky MP; Besner GE
J Pediatr Surg; 2002 Jul; 37(7):1081-7; discussion 1081-7. PubMed ID: 12077776
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
